Endocannabinoid signaling regulates the reinforcing and psychostimulant effects of ketamine in mice
Ketamine is used for sedation and treatment of depression, but is also a drug of abuse. Here the authors show that ketamine modulates the endocannabinoid system in mice, and that this may contribute to its psychoactive effects.
Guardado en:
Autores principales: | Wei Xu, Hongchun Li, Liang Wang, Jiamei Zhang, Chunqi Liu, Xuemei Wan, Xiaochong Liu, Yiming Hu, Qiyao Fang, Yuanyuan Xiao, Qian Bu, Hongbo Wang, Jingwei Tian, Yinglan Zhao, Xiaobo Cen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5d2e1408f3a74c629dd722b4d53c0d12 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Immunoregulation and antidepressant effect of ketamine
por: Zhang Nan, et al.
Publicado: (2021) -
Effect of Psychostimulants on Distinct Attentional Parameters in Attentional Deficit/Hyperactivity Disorder
por: LÓPEZ,JAVIER, et al.
Publicado: (2004) -
Psychostimulants and opioids differentially influence the epigenetic modification of histone acetyltransferase and histone deacetylase in astrocytes.
por: Mayur Doke, et al.
Publicado: (2021) -
Care and feeding of the endocannabinoid system: a systematic review of potential clinical interventions that upregulate the endocannabinoid system.
por: John M McPartland, et al.
Publicado: (2014) -
Role of endocannabinoids in regulating drug dependence
por: Daniela Parolaro, et al.
Publicado: (2007)